We are live on
!
Find out more
AstraZeneca
AZN
AZN
465 hedge funds and large institutions have $12.3B invested in AstraZeneca in 2017 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 153 increasing their positions, 142 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
128% more call options, than puts
Call options by funds: $566M | Put options by funds: $248M
29% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 42
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
11% more capital invested
Capital invested by funds: $11.1B → $12.3B (+$1.21B)
1% more funds holding
Funds holding: 460 → 465 (+5)
8% more repeat investments, than reductions
Existing positions increased: 153 | Existing positions reduced: 142
0.19% more ownership
Funds ownership: 14.05% → 14.25% (+0.19%)
Holders
465
Holders Change
+5
Holders Change %
+1.09%
% of All Funds
11.59%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.17%
New
54
Increased
153
Reduced
142
Closed
42
Calls
$566M
Puts
$248M
Net Calls
+$318M
Net Calls Change
+$49.2M
Top Buyers
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$299M |
| 2 |
Primecap Management
Pasadena,
California
|
+$117M |
| 3 |
Goldman Sachs
New York
|
+$40.9M |
| 4 |
LCM
Laurion Capital Management
New York
|
+$22.9M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$21.6M |
